Gender Identity Disparities in Cancer Screening Behaviors
Gender Identity Disparities in Cancer Screening Behaviors
复制标题
DOI：
10.1016/j.amepre.2017.11.009
复制
发表时间：
2018-03-01
影响因子：
5.5
通讯作者：
Baker, Kellan E.
中科院分区：
文献类型：
--
作者：
Tabaac, Ariella R.;Sutter, Megan E.;Baker, Kellan E.
导言：据报告，由于歧视和缺乏知识渊博的护理，变性人和性别不一致的成年人获得保健服务的机会减少。本研究旨在通过性别认同来确定乳腺癌、宫颈癌、前列腺癌和结直肠癌筛查行为的比例，从而为跨性别和性别不一致的个体提供新生的癌症预防文献。方法：利用2014-2016年行为风险因素监测系统调查中公开获得的去识别数据，在控制医疗保健可及性、社会人口统计学和调查年份的情况下，按性别认同评估癌症筛查率。2017年进行了分析。结果：加权卡方检验发现，在终生结直肠癌筛查、巴氏涂片检查、前列腺特异性抗原检查、与医疗保健提供者讨论前列腺特异性抗原检查的优点/缺点以及最新结直肠癌筛查和巴氏涂片检查中，性别认同的癌症筛查行为比例存在显著差异
Introduction: Transgender (trans) and gender-nonconforming adults have reported reduced access to health care because of discrimination and lack of knowledgeable care. This study aimed to contribute to the nascent cancer prevention literature among trans and gender-nonconforming individuals by ascertaining rates of breast, cervical, prostate, and colorectal cancer screening behaviors by gender identity.Methods: Publicly available de-identified data from the 2014-2016 Behavioral Risk Factor Surveillance System surveys were utilized to evaluate rates of cancer screenings by gender identity, while controlling for healthcare access, sociodemographics, and survey year. Analyses were conducted in 2017.Results: Weighted chi-square tests identified significant differences in the proportion of cancer screening behaviors by gender identity among lifetime colorectal cancer screenings, Pap tests, prostate-specific antigen tests, discussing prostate-specific antigen test advantages/disadvantages with their healthcare provider, and up-to-date colorectal cancer screenings and Pap tests (p